Skip to main content
Solutions
For biologics developersFor vaccine developersCustomized solutions
Platforms
myADAmySURFACEmyNEOView all platforms →
Technology
ImmunoEngineneoMSneoIMCamyotopes
Publications
Assets
Partnered programsInternal programsAsset library
Careers
ApplicationCompany culture
News & Events
About Us
HistoryTeamBoardAdvisors
Contact
TECHNOLOGY PAPER

myEPITOPE – Next-generation immunogenicity prediction

Technology paper on myEPITOPE: high-precision immunogenicity prediction for CD8+ T-cell responses using the proprietary neoIM algorithm, enabling de-risked preclinical validation.

Download PDF ↓View solution →All publications →

Your browser does not support embedded PDFs. Open the PDF directly →

For the best reading experience on mobile, open the PDF in a new tab.

Neoantigen and target discovery for the therapies you are building.

Solutions

AllmyADAmySURFACEmyNEOmySHAREDmyCONSTRUCTmyRNA

Technology

OverviewImmunoEngineneoMSneoIMCamyotopesHow we differ

Company

About UsAssetsPublicationsFAQNews & EventsCareersContact

© 2026 myNEO

myNEO BV · Ottergemsesteenweg 439, 9000 Ghent · BE0715710837

PrivacyTerms
info@myneotx.com